nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—Condition aggravated—Memantine—Alzheimer's disease	0.0724	0.136	CcSEcCtD
Fluocinonide—Application site burn—Rivastigmine—Alzheimer's disease	0.0618	0.116	CcSEcCtD
Fluocinonide—Skin striae—Donepezil—Alzheimer's disease	0.0458	0.0858	CcSEcCtD
Fluocinonide—SMO—embryo—Alzheimer's disease	0.0323	0.208	CbGeAlD
Fluocinonide—Application site pain—Rivastigmine—Alzheimer's disease	0.0294	0.0551	CcSEcCtD
Fluocinonide—Glycosuria—Donepezil—Alzheimer's disease	0.018	0.0337	CcSEcCtD
Fluocinonide—SMO—nervous system—Alzheimer's disease	0.0155	0.0999	CbGeAlD
Fluocinonide—SMO—central nervous system—Alzheimer's disease	0.0149	0.0962	CbGeAlD
Fluocinonide—SMO—cerebellum—Alzheimer's disease	0.0146	0.094	CbGeAlD
Fluocinonide—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.0128	0.0239	CcSEcCtD
Fluocinonide—Skin exfoliation—Memantine—Alzheimer's disease	0.0126	0.0236	CcSEcCtD
Fluocinonide—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.0124	0.0231	CcSEcCtD
Fluocinonide—SMO—brain—Alzheimer's disease	0.0119	0.0764	CbGeAlD
Fluocinonide—Hyperglycaemia—Galantamine—Alzheimer's disease	0.0106	0.0199	CcSEcCtD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—Alzheimer's disease	0.0103	0.0338	CbGpPWpGaD
Fluocinonide—Dry skin—Donepezil—Alzheimer's disease	0.0097	0.0182	CcSEcCtD
Fluocinonide—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00946	0.0177	CcSEcCtD
Fluocinonide—Dry skin—Memantine—Alzheimer's disease	0.0088	0.0165	CcSEcCtD
Fluocinonide—Dry skin—Rivastigmine—Alzheimer's disease	0.00861	0.0161	CcSEcCtD
Fluocinonide—Nasopharyngitis—Memantine—Alzheimer's disease	0.00859	0.0161	CcSEcCtD
Fluocinonide—SERPINA6—nervous system—Alzheimer's disease	0.00855	0.055	CbGeAlD
Fluocinonide—Immune system disorder—Galantamine—Alzheimer's disease	0.00853	0.016	CcSEcCtD
Fluocinonide—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.0084	0.0157	CcSEcCtD
Fluocinonide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00825	0.0154	CcSEcCtD
Fluocinonide—SERPINA6—central nervous system—Alzheimer's disease	0.00823	0.053	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—Alzheimer's disease	0.00805	0.0518	CbGeAlD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—IAPP—Alzheimer's disease	0.0078	0.0257	CbGpPWpGaD
Fluocinonide—NR3C1—embryo—Alzheimer's disease	0.0078	0.0502	CbGeAlD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—CRH—Alzheimer's disease	0.00757	0.0249	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Memantine—Alzheimer's disease	0.00749	0.014	CcSEcCtD
Fluocinonide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00733	0.0137	CcSEcCtD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00719	0.0237	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00695	0.013	CcSEcCtD
Fluocinonide—NR3C1—forebrain—Alzheimer's disease	0.0069	0.0444	CbGeAlD
Fluocinonide—Nervous system disorder—Galantamine—Alzheimer's disease	0.00658	0.0123	CcSEcCtD
Fluocinonide—SERPINA6—brain—Alzheimer's disease	0.00654	0.042	CbGeAlD
Fluocinonide—Skin disorder—Galantamine—Alzheimer's disease	0.00652	0.0122	CcSEcCtD
Fluocinonide—Erythema—Donepezil—Alzheimer's disease	0.00637	0.0119	CcSEcCtD
Fluocinonide—NR3C1—telencephalon—Alzheimer's disease	0.00634	0.0408	CbGeAlD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—GSK3B—Alzheimer's disease	0.00623	0.0205	CbGpPWpGaD
Fluocinonide—Immune system disorder—Memantine—Alzheimer's disease	0.006	0.0112	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—CELF1—Alzheimer's disease	0.00575	0.0189	CbGpPWpGaD
Fluocinonide—Erythema—Rivastigmine—Alzheimer's disease	0.00566	0.0106	CcSEcCtD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—GSK3B—Alzheimer's disease	0.0056	0.0184	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Alzheimer's disease	0.00536	0.0177	CbGpPWpGaD
Fluocinonide—Infection—Donepezil—Alzheimer's disease	0.00517	0.00967	CcSEcCtD
Fluocinonide—Nervous system disorder—Donepezil—Alzheimer's disease	0.0051	0.00954	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.00495	0.0163	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Galantamine—Alzheimer's disease	0.00494	0.00925	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00478	0.00896	CcSEcCtD
Fluocinonide—Infection—Memantine—Alzheimer's disease	0.00469	0.00878	CcSEcCtD
Fluocinonide—Nervous system disorder—Memantine—Alzheimer's disease	0.00463	0.00867	CcSEcCtD
Fluocinonide—Infection—Rivastigmine—Alzheimer's disease	0.00459	0.00859	CcSEcCtD
Fluocinonide—Skin disorder—Memantine—Alzheimer's disease	0.00459	0.00858	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.00458	0.0151	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00453	0.00848	CcSEcCtD
Fluocinonide—Skin disorder—Rivastigmine—Alzheimer's disease	0.00449	0.0084	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.00445	0.0146	CbGpPWpGaD
Fluocinonide—Pain—Donepezil—Alzheimer's disease	0.00445	0.00832	CcSEcCtD
Fluocinonide—Dizziness—Galantamine—Alzheimer's disease	0.00444	0.0083	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—CCR5—Alzheimer's disease	0.00426	0.014	CbGpPWpGaD
Fluocinonide—Rash—Galantamine—Alzheimer's disease	0.00423	0.00792	CcSEcCtD
Fluocinonide—Dermatitis—Galantamine—Alzheimer's disease	0.00423	0.00791	CcSEcCtD
Fluocinonide—Headache—Galantamine—Alzheimer's disease	0.0042	0.00787	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—HTR2A—Alzheimer's disease	0.00417	0.0137	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.00416	0.0137	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.00408	0.0135	CbGpPWpGaD
Fluocinonide—Pain—Memantine—Alzheimer's disease	0.00404	0.00756	CcSEcCtD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—AKT1—Alzheimer's disease	0.00401	0.0132	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—Alzheimer's disease	0.00399	0.0132	CbGpPWpGaD
Fluocinonide—Pain—Rivastigmine—Alzheimer's disease	0.00395	0.00739	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—PYY—Alzheimer's disease	0.00394	0.013	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Donepezil—Alzheimer's disease	0.00383	0.00717	CcSEcCtD
Fluocinonide—NR3C1—nervous system—Alzheimer's disease	0.00375	0.0241	CbGeAlD
Fluocinonide—Pruritus—Donepezil—Alzheimer's disease	0.00368	0.00689	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.00362	0.0119	CbGpPWpGaD
Fluocinonide—NR3C1—central nervous system—Alzheimer's disease	0.00361	0.0232	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.00356	0.0117	CbGpPWpGaD
Fluocinonide—NR3C1—cerebellum—Alzheimer's disease	0.00352	0.0227	CbGeAlD
Fluocinonide—Hypersensitivity—Memantine—Alzheimer's disease	0.00348	0.00651	CcSEcCtD
Fluocinonide—Dizziness—Donepezil—Alzheimer's disease	0.00344	0.00644	CcSEcCtD
Fluocinonide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.0034	0.00637	CcSEcCtD
Fluocinonide—Pruritus—Memantine—Alzheimer's disease	0.00334	0.00625	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CDK5—Alzheimer's disease	0.00331	0.0109	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR6—Alzheimer's disease	0.00329	0.0108	CbGpPWpGaD
Fluocinonide—Rash—Donepezil—Alzheimer's disease	0.00328	0.00614	CcSEcCtD
Fluocinonide—Dermatitis—Donepezil—Alzheimer's disease	0.00328	0.00613	CcSEcCtD
Fluocinonide—Pruritus—Rivastigmine—Alzheimer's disease	0.00327	0.00612	CcSEcCtD
Fluocinonide—Headache—Donepezil—Alzheimer's disease	0.00326	0.0061	CcSEcCtD
Fluocinonide—SMO—Hedgehog 'off' state—GSK3B—Alzheimer's disease	0.00316	0.0104	CbGpPWpGaD
Fluocinonide—Dizziness—Memantine—Alzheimer's disease	0.00312	0.00584	CcSEcCtD
Fluocinonide—Dizziness—Rivastigmine—Alzheimer's disease	0.00305	0.00572	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—Alzheimer's disease	0.00305	0.01	CbGpPWpGaD
Fluocinonide—Rash—Memantine—Alzheimer's disease	0.00298	0.00557	CcSEcCtD
Fluocinonide—Dermatitis—Memantine—Alzheimer's disease	0.00297	0.00557	CcSEcCtD
Fluocinonide—Headache—Memantine—Alzheimer's disease	0.00296	0.00554	CcSEcCtD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—Alzheimer's disease	0.00294	0.00969	CbGpPWpGaD
Fluocinonide—Rash—Rivastigmine—Alzheimer's disease	0.00291	0.00545	CcSEcCtD
Fluocinonide—Dermatitis—Rivastigmine—Alzheimer's disease	0.00291	0.00545	CcSEcCtD
Fluocinonide—Headache—Rivastigmine—Alzheimer's disease	0.00289	0.00542	CcSEcCtD
Fluocinonide—NR3C1—brain—Alzheimer's disease	0.00286	0.0184	CbGeAlD
Fluocinonide—SMO—Signaling by Hedgehog—GSK3B—Alzheimer's disease	0.00282	0.00929	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GAL—Alzheimer's disease	0.00273	0.009	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.00273	0.00897	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.00265	0.00874	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.00263	0.00868	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.00262	0.00862	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.00254	0.00835	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.00233	0.00766	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—AKT1—Alzheimer's disease	0.00223	0.00733	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00216	0.00713	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—NPY—Alzheimer's disease	0.00215	0.00707	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—IAPP—Alzheimer's disease	0.00213	0.00702	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CRH—Alzheimer's disease	0.00207	0.00682	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.00205	0.00676	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.00204	0.00673	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PYY—Alzheimer's disease	0.00202	0.00666	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—NPS—Alzheimer's disease	0.00196	0.00646	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.00192	0.00632	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.00188	0.00619	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.00188	0.00619	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—SST—Alzheimer's disease	0.00187	0.00617	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00184	0.00606	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00184	0.00606	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.00184	0.00606	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—APP—Alzheimer's disease	0.00183	0.00601	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00178	0.00587	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.00178	0.00587	CbGpPWpGaD
Fluocinonide—Triamcinolone—BCHE—Alzheimer's disease	0.00177	0.266	CrCbGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.00177	0.00582	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CDK5—Alzheimer's disease	0.00175	0.00578	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.00173	0.0057	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.00171	0.00565	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR6—Alzheimer's disease	0.00169	0.00556	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.00165	0.00544	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00156	0.00515	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.00154	0.00508	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.0015	0.00495	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.0015	0.00492	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.00148	0.00489	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00147	0.00484	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.00147	0.00483	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00144	0.00476	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.00141	0.00464	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GAL—Alzheimer's disease	0.0014	0.00462	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TTR—Alzheimer's disease	0.00137	0.0045	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.00136	0.00448	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.00135	0.00446	CbGpPWpGaD
Fluocinonide—Dexamethasone—NOS2—Alzheimer's disease	0.00135	0.203	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00132	0.00435	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.00131	0.0043	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.00127	0.00418	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.00126	0.00415	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.00126	0.00414	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.00125	0.00412	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.00122	0.00403	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCR5—Alzheimer's disease	0.00121	0.00397	CbGpPWpGaD
Fluocinonide—Ciclesonide—CYP2D6—Alzheimer's disease	0.0012	0.18	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.0012	0.00395	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PYY—Alzheimer's disease	0.0012	0.00394	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00119	0.00391	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2A—Alzheimer's disease	0.00118	0.00389	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.00116	0.0038	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.00115	0.0038	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.00114	0.00376	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.00114	0.00375	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00112	0.00367	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPY—Alzheimer's disease	0.0011	0.00363	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IAPP—Alzheimer's disease	0.00109	0.00361	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00108	0.00357	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00108	0.00357	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CRH—Alzheimer's disease	0.00106	0.0035	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.00106	0.00349	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.00104	0.00342	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDK5—Alzheimer's disease	0.00104	0.00341	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—F2—Alzheimer's disease	0.00104	0.00341	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.00103	0.00338	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.00101	0.00334	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPS—Alzheimer's disease	0.00101	0.00332	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.001	0.0033	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR6—Alzheimer's disease	0.000998	0.00328	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.00099	0.00326	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.000964	0.00317	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GAB2—Alzheimer's disease	0.000961	0.00317	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—SST—Alzheimer's disease	0.000961	0.00317	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—APP—Alzheimer's disease	0.000937	0.00308	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL2—Alzheimer's disease	0.000923	0.00304	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000923	0.00304	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.000921	0.00303	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.000914	0.00301	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PSENEN—Alzheimer's disease	0.000906	0.00298	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APH1A—Alzheimer's disease	0.000893	0.00294	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000884	0.00291	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000882	0.0029	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.000878	0.00289	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.000873	0.00287	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.00087	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCSTN—Alzheimer's disease	0.00087	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LRP1—Alzheimer's disease	0.000848	0.00279	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000833	0.00274	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GAL—Alzheimer's disease	0.000828	0.00273	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GFAP—Alzheimer's disease	0.000828	0.00273	CbGpPWpGaD
Fluocinonide—Triamcinolone—PTGS2—Alzheimer's disease	0.000816	0.122	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00081	0.00267	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000777	0.00256	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000752	0.00248	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.000737	0.00243	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.000736	0.00242	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—A2M—Alzheimer's disease	0.00073	0.0024	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000719	0.00237	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PSEN2—Alzheimer's disease	0.000707	0.00233	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000684	0.00225	CbGpPWpGaD
Fluocinonide—Betamethasone—PTGS2—Alzheimer's disease	0.000668	0.1	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000654	0.00215	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.000652	0.00215	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPY—Alzheimer's disease	0.000651	0.00214	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IAPP—Alzheimer's disease	0.000647	0.00213	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.000641	0.00211	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.000632	0.00208	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.000629	0.00207	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CRH—Alzheimer's disease	0.000628	0.00207	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.000622	0.00205	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR5—Alzheimer's disease	0.000619	0.00204	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.000612	0.00202	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.000608	0.002	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000606	0.002	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000603	0.00198	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000598	0.00197	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPS—Alzheimer's disease	0.000595	0.00196	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000592	0.00195	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTK2B—Alzheimer's disease	0.000584	0.00192	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SST—Alzheimer's disease	0.000568	0.00187	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GAB2—Alzheimer's disease	0.000568	0.00187	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK2—Alzheimer's disease	0.000568	0.00187	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CALM1—Alzheimer's disease	0.000565	0.00186	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GSK3A—Alzheimer's disease	0.000563	0.00185	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APP—Alzheimer's disease	0.000553	0.00182	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000546	0.0018	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—F2—Alzheimer's disease	0.000531	0.00175	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLCB1—Alzheimer's disease	0.000522	0.00172	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.000492	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NGFR—Alzheimer's disease	0.000487	0.0016	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CREB1—Alzheimer's disease	0.000484	0.00159	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADAM10—Alzheimer's disease	0.000476	0.00157	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL2—Alzheimer's disease	0.000474	0.00156	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP2D6—Alzheimer's disease	0.000463	0.0695	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	0.000451	0.00148	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—S100B—Alzheimer's disease	0.00045	0.00148	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	0.000434	0.00143	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF2—Alzheimer's disease	0.000428	0.00141	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—TFAM—Alzheimer's disease	0.00042	0.00138	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1R—Alzheimer's disease	0.000414	0.00136	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000405	0.00133	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000404	0.00133	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LPL—Alzheimer's disease	0.000397	0.00131	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	0.000397	0.00131	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MEF2C—Alzheimer's disease	0.000394	0.0013	CbGpPWpGaD
Fluocinonide—Dexamethasone—PTGS2—Alzheimer's disease	0.000389	0.0583	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—PRKCG—Alzheimer's disease	0.000386	0.00127	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NGF—Alzheimer's disease	0.000376	0.00124	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.00037	0.00122	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	0.000366	0.00121	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR5—Alzheimer's disease	0.000366	0.0012	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	0.000364	0.0012	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2A—Alzheimer's disease	0.000358	0.00118	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000343	0.00113	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—Alzheimer's disease	0.00034	0.00112	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CALM1—Alzheimer's disease	0.000334	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LEP—Alzheimer's disease	0.000333	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—Alzheimer's disease	0.000333	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CAV1—Alzheimer's disease	0.00033	0.00109	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ESR1—Alzheimer's disease	0.000318	0.00105	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—F2—Alzheimer's disease	0.000314	0.00103	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000307	0.00101	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000294	0.000969	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GSK3B—Alzheimer's disease	0.000288	0.000949	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CREB1—Alzheimer's disease	0.000286	0.000942	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INS—Alzheimer's disease	0.000284	0.000936	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL2—Alzheimer's disease	0.00028	0.000921	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1—Alzheimer's disease	0.000275	0.000906	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—Alzheimer's disease	0.000275	0.000904	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000256	0.000845	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	0.000253	0.000833	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOS3—Alzheimer's disease	0.000249	0.000821	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000248	0.000816	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000237	0.000782	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000234	0.000771	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—Alzheimer's disease	0.000212	0.000697	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—Alzheimer's disease	0.00021	0.000693	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK8—Alzheimer's disease	0.000195	0.000641	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—Alzheimer's disease	0.000194	0.000639	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—Alzheimer's disease	0.00018	0.000592	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—Alzheimer's disease	0.000165	0.000543	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—Alzheimer's disease	0.000136	0.000447	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—Alzheimer's disease	0.000124	0.000409	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR1—Alzheimer's disease	0.000123	0.000407	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	0.000119	0.000393	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—Alzheimer's disease	0.000115	0.000377	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—Alzheimer's disease	0.000113	0.000371	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—Alzheimer's disease	4.45e-05	0.000147	CbGpPWpGaD
